Alanine aminotransferase (ALT) stability testing is a systematic evaluation of how well ALT enzyme activity is preserved in clinical specimens, calibrators, controls, and assay reagents under defined storage, transport, and handling conditions. This technical article outlines the sample types, test parameters, study designs, analytical methods, and regulatory standards involved in ALT stability studies for laboratory medicine and in vitro diagnostic applications. Reliable stability data are essential for establishing expiration dating, validating pre-analytical workflows, and ensuring the accuracy of ALT results used in liver function assessment.
Technical Overview
Alanine aminotransferase (ALT, EC 2.6.1.2), formerly known as serum glutamate-pyruvate transminase (SGPT), is a pyridoxal phosphate-dependent enzyme that catalyzes the reversible transfer of an amino group from L-alanine to alpha-ketoglutarate, producing pyruvate and L-glutamate. Because ALT is highly concentrated in hepatocytes, its activity in serum or plasma serves as a sensitive and widely used biomarker of hepatocellular injury, and it is a core component of liver function panels, blood donor screening algorithms, pharmaceutical drug-safety monitoring, and occupational health surveillance programs.
A stability test for ALT determines the extent to which measurable enzyme activity is retained over time when a specimen or product is exposed to defined environmental conditions such as temperature, humidity, light exposure, and mechanical stress. Enzyme activity may decline due to thermal denaturation, or it may appear to increase in unseparated whole blood due to continued cellular leakage, which is why empirical testing under strictly controlled conditions is required. For in vitro diagnostic (IVD) reagents, calibrators, and control materials, stability claims must be substantiated in accordance with recognized standards such as ISO 23640 and CLSI EP25-A, whereas clinical specimen stability is evaluated using protocols consistent with CLSI guidance on specimen collection, transport, and handling.
Key variables that influence ALT stability during testing include the following:
- Storage temperature, typically evaluated at 2–8 °C, 18–25 °C, 30–37 °C, and frozen conditions at −20 °C or below.
- Time interval between collection, separation, and analysis, including contact time with cellular components.
- Sample matrix, including plain serum, gel-separated serum, and anticoagulated plasma.
- Freeze–thaw cycling, which tests resistance to repeated solid–liquid phase transitions.
- Matrix additives, stabilizers, preservatives, and lyophilization processes used in reagent or control manufacturing.
- Interfering conditions such as hemolysis, which can bias ALT results through optical and biochemical effects.
Testing Samples
Serum Specimens
Serum is the most common matrix for ALT measurement and stability evaluation. Venous blood is collected into plain tubes or serum separator tubes (SSTs) containing a clot activator and separator gel, allowed to clot for 30 minutes, and centrifuged to obtain cell-free serum. ALT is generally considered one of the more stable serum enzymes: activity is typically preserved for approximately 24–72 hours at ambient temperature (20–25 °C) and for up to one week at refrigerated temperature (2–8 °C) once serum is separated from the clot. Stability protocols compare results at defined time points against an immediate baseline measurement to quantify any drift.
Plasma Specimens
Lithium heparin plasma is an acceptable alternative matrix for ALT and offers the advantage of immediate processing without clotting delay. EDTA plasma may also be used with assays validated for this anticoagulant, although method-specific interference must be excluded. Citrate plasma is generally avoided for enzyme activity reporting because the liquid anticoagulant dilutes the specimen and artificially lowers measured activity. Plasma stability studies additionally monitor for the presence of fibrin clots or platelet contamination, which can affect analytical performance during storage.
Reagents, Calibrators, and Control Materials
For IVD manufacturers, stability testing covers ALT reagent kits in liquid, liquid-stable, or lyophilized form, along with matching calibrators and quality control sera. Closed-vial stability, open-vial stability, and reconstituted stability are each evaluated separately because exposure to air, evaporation, and microbial contamination accelerate degradation. These products are tested across multiple independent lots, typically at least three, to ensure that stability conclusions are representative of routine manufacturing variability.
Reference and Proficiency Testing Materials
Reference materials and external quality assessment (EQA) samples used for ALT harmonization require rigorous stability verification, since assigned target values must remain valid throughout distribution and storage. These studies often include multi-temperature monitoring, transport simulation, and retesting after real-world shipping to participant laboratories.
Testing Items
A well-designed ALT stability study measures and documents the following parameters at every protocol-defined time point and condition:
- ALT activity in U/L (or µkat/L), measured with a validated assay traceable to the IFCC reference measurement procedure.
- Percent recovery, calculated as measured activity at each interval divided by the baseline activity multiplied by 100.
- Mean bias relative to baseline, reported with 95% confidence intervals to determine statistical significance.
- Reagent performance indicators, including blank reaction rate, starting absorbance at 340 nm, lag phase duration, and linearity of the kinetic reaction.
- Physical and chemical attributes such as reagent appearance, turbidity, pH, and reconstitution time for lyophilized products.
- Within-run precision at each stability point, to confirm that analytical variation has not degraded beyond specification.
- Verification that results remain within the defined acceptance limit, commonly ±10% of baseline or within the allowable total error for ALT, which is approximately 20% under commonly applied proficiency criteria.
Testing Methods
Analytical Measurement Principle
ALT activity is measured using the kinetic ultraviolet method recommended by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). ALT catalyzes the transamination of L-alanine with 2-oxoglutarate to form pyruvate and L-glutamate; pyruvate is then reduced to lactate by lactate dehydrogenase with concomitant oxidation of NADH to NAD+. The decrease in absorbance at 340 nm, monitored at 37 °C, is directly proportional to ALT catalytic activity. Modern formulations include pyridoxal-5-phosphate to ensure full activation of apoenzyme, improving comparability across specimens. All measurements in a stability study should be performed on a single calibrated automated biochemistry analyzer using one reagent lot to isolate the stability variable from analytical variation.
Real-Time Long-Term Stability
In the real-time design, samples or products are stored at their intended labeled storage temperature and tested at predefined intervals, such as 0, 1, 2, 3, 6, 9, and 12 months, continuing through and beyond the intended expiration date. A minimum of two or three replicates per condition is typical, and regression analysis of activity versus time is used to estimate the point at which the lower confidence limit of predicted activity crosses the acceptance limit. This design provides the highest-confidence evidence supporting shelf-life claims.
Accelerated Stability Testing
Accelerated studies expose samples to elevated temperatures, commonly 37 °C, 40 °C, or 45 °C, to increase degradation rates and generate predictive data in a shortened timeframe. Degradation kinetics are analyzed using Arrhenius modeling or the Q10 approximation, in which the reaction rate approximately doubles for each 10 °C rise in temperature. Accelerated data support preliminary shelf-life estimates, shipping excursion claims, and design comparisons, but they must be confirmed by ongoing real-time studies, since enzyme inactivation does not always follow ideal kinetics.
In-Use and On-Board Stability
This protocol evaluates products under realistic operating conditions: reagent vials are opened, placed on the analyzer in refrigerated reagent positions, and assayed periodically over the claimed on-board period, for example 14 to 30 days. Opened vials stored at 2–8 °C are similarly tested for open-vial claims. This ensures that calibration frequency recommendations and onboard expiration settings are scientifically justified.
Freeze–Thaw and Transport Simulation
Aliquots of serum or control material undergo repeated freeze–thaw cycles, commonly three or more, with ALT activity measured after each cycle to confirm that changes remain within acceptance limits. Transport simulation exposes samples to temperature profiles mimicking summer and winter shipping conditions, including deliberate excursions above 30 °C, and may incorporate mechanical vibration testing for products distributed globally.
Data Analysis and Acceptance Criteria
Results are analyzed using linear or nonlinear regression of activity versus time for each storage condition, with calculation of the slope, intercept, and one-sided 95% confidence limits. The stability limit is defined as the earliest time at which the statistically bounded predicted activity falls outside the acceptance window. For specimen stability, paired comparison against a fresh baseline, combined with allowable total error thresholds, determines the maximum permissible time from collection to analysis for each temperature condition.
Applications
ALT stability testing supports quality and compliance across multiple sectors of laboratory medicine and diagnostics:
- IVD manufacturers use stability data to assign expiration dates, storage labeling, and on-board stability claims in submission files under ISO 13485 quality management systems and in regulatory filings.
- Clinical laboratories apply specimen stability limits to define acceptable transport windows for send-out testing, satellite collection sites, and delayed centrifugation scenarios.
- Biobanks and research repositories rely on ALT stability data to validate long-term frozen storage at −70 °C to −80 °C and to establish aliquoting procedures that avoid repeated freeze–thaw exposure.
- Reference material producers and EQA organizers use stability studies to certify target value validity throughout distribution cycles.
- Pharmaceutical sponsors and central laboratories incorporate ALT stability findings into clinical trial sample-management plans, ensuring that hepatic safety data from global sites remain comparable.
- Blood donation services verify that ALT screening results remain valid under the temperature and time conditions encountered during donor sample transport.
FAQ
How stable is ALT in serum at room temperature?
ALT activity in properly separated serum is generally stable for approximately 24 to 72 hours at 20–25 °C, although laboratories should validate exact limits for their own collection systems and assays. Prolonged contact with the clot in uncentrifuged tubes can alter results, so timely separation is recommended.
Can ALT samples be frozen for later analysis?
Yes. ALT is well preserved at −20 °C for several weeks and at −70 °C or −80 °C for months. Studies should include freeze–thaw testing, and aliquoting before freezing is preferred so that samples are never subjected to more than about three cycles.
What acceptance criterion is typically used in ALT stability testing?
A recovery window of 90–110% of baseline activity is commonly applied, and acceptance may alternatively be defined against the allowable total error for ALT, which is approximately 20% in widely used proficiency programs. The criterion must be pre-specified in the study protocol.
Which standards govern ALT reagent stability studies?
ISO 23640 defines requirements for stability evaluation of IVD reagents, and CLSI EP25-A provides the accepted protocol for establishing and verifying reagent shelf-life using regression-based statistical analysis. Specimen handling studies reference CLSI guidance on venous blood collection and processing.
Why is hemolysis a concern in ALT stability testing?
Hemolysis releases intracellular components and changes the optical background of the specimen, which can bias kinetic ALT measurements independently of true enzyme stability. Stability protocols therefore document and control hemolysis indices, and grossly hemolyzed specimens are excluded or flagged.
How many lots and replicates are required for a reagent stability claim?
Establishment of a shelf-life claim typically requires at least three independent manufacturing lots tested at multiple intervals with duplicate or triplicate measurements per condition, followed by ongoing real-time verification of each new lot through its claimed expiration date.
